ATE314846T1 - Synergistische wirkungen von amlodipin und dem hydroxylierten metabolit von atorvastatin - Google Patents

Synergistische wirkungen von amlodipin und dem hydroxylierten metabolit von atorvastatin

Info

Publication number
ATE314846T1
ATE314846T1 AT00928200T AT00928200T ATE314846T1 AT E314846 T1 ATE314846 T1 AT E314846T1 AT 00928200 T AT00928200 T AT 00928200T AT 00928200 T AT00928200 T AT 00928200T AT E314846 T1 ATE314846 T1 AT E314846T1
Authority
AT
Austria
Prior art keywords
amlodipine
atorvastatin
synergistic effects
hydroxylated metabolite
hydroxylated
Prior art date
Application number
AT00928200T
Other languages
English (en)
Inventor
R Preston Mason
Original Assignee
R Preston Mason
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27494873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE314846(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Preston Mason filed Critical R Preston Mason
Application granted granted Critical
Publication of ATE314846T1 publication Critical patent/ATE314846T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AT00928200T 1999-04-23 2000-04-18 Synergistische wirkungen von amlodipin und dem hydroxylierten metabolit von atorvastatin ATE314846T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13066599P 1999-04-23 1999-04-23
US14530599P 1999-07-23 1999-07-23
US15112199P 1999-08-27 1999-08-27
US16659299P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
ATE314846T1 true ATE314846T1 (de) 2006-02-15

Family

ID=27494873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00928200T ATE314846T1 (de) 1999-04-23 2000-04-18 Synergistische wirkungen von amlodipin und dem hydroxylierten metabolit von atorvastatin

Country Status (30)

Country Link
EP (1) EP1173172B1 (de)
JP (1) JP2002542289A (de)
KR (1) KR20020024581A (de)
CN (1) CN1351492A (de)
AP (1) AP2001002324A0 (de)
AT (1) ATE314846T1 (de)
AU (1) AU4647000A (de)
BG (1) BG106115A (de)
BR (1) BR0010689A (de)
CA (1) CA2370639A1 (de)
CZ (1) CZ20013793A3 (de)
DE (1) DE60025344T2 (de)
DK (1) DK1173172T3 (de)
EA (1) EA004435B1 (de)
EE (1) EE200100555A (de)
ES (1) ES2256005T3 (de)
HK (1) HK1043741A1 (de)
HU (1) HUP0201016A3 (de)
IL (1) IL146085A0 (de)
IS (1) IS6118A (de)
NO (1) NO20015128L (de)
OA (1) OA11870A (de)
PE (1) PE20010055A1 (de)
PL (1) PL351408A1 (de)
PT (1) PT1173172E (de)
SK (1) SK15382001A3 (de)
SV (1) SV2002000058A (de)
TN (1) TNSN00085A1 (de)
UY (1) UY26118A1 (de)
WO (1) WO2000064443A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030324A1 (es) * 2001-07-31 2003-04-03 Warner Lambert Co Composiciones farmaceuticas de amlodipina y atorvastatina
CN100430057C (zh) * 2005-04-08 2008-11-05 石药集团中奇制药技术（石家庄）有限公司 左旋氨氯地平和阿托伐他汀的药物组合物
KR101467110B1 (ko) * 2013-08-01 2014-11-28 한국방송공사 코로나링을 구비한 지선애자

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385929A (en) * 1994-05-04 1995-01-31 Warner-Lambert Company [(Hydroxyphenylamino) carbonyl] pyrroles
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.

Also Published As

Publication number Publication date
EA200101112A1 (ru) 2002-06-27
EP1173172A1 (de) 2002-01-23
NO20015128D0 (no) 2001-10-19
WO2000064443A1 (en) 2000-11-02
EA004435B1 (ru) 2004-04-29
NO20015128L (no) 2001-12-20
IL146085A0 (en) 2002-07-25
UY26118A1 (es) 2001-03-16
KR20020024581A (ko) 2002-03-30
BG106115A (bg) 2002-11-29
DK1173172T3 (da) 2006-05-15
CN1351492A (zh) 2002-05-29
DE60025344D1 (de) 2006-03-30
PL351408A1 (en) 2003-04-22
AU4647000A (en) 2000-11-10
HK1043741A1 (zh) 2002-09-27
EE200100555A (et) 2002-12-16
EP1173172B1 (de) 2006-01-04
OA11870A (en) 2006-03-27
AP2001002324A0 (en) 2001-12-31
DE60025344T2 (de) 2006-09-28
HUP0201016A3 (en) 2003-03-28
CZ20013793A3 (cs) 2002-05-15
EP1173172A4 (de) 2002-08-07
SK15382001A3 (sk) 2002-05-09
SV2002000058A (es) 2002-02-05
PE20010055A1 (es) 2001-01-30
IS6118A (is) 2001-10-19
PT1173172E (pt) 2006-05-31
CA2370639A1 (en) 2000-11-02
WO2000064443A9 (en) 2002-08-29
ES2256005T3 (es) 2006-07-16
TNSN00085A1 (fr) 2005-11-10
JP2002542289A (ja) 2002-12-10
HUP0201016A2 (hu) 2002-07-29
BR0010689A (pt) 2002-02-19

Similar Documents

Publication Publication Date Title
DE69835245D1 (de) Therapeutische Zusammensetzungen, enthaltend Amlodipin und Atorvastatin
IS5345A (is) Samsett meðferð sem inniheldur amlódipín og statín efnasambönd
ATE385793T1 (de) Pharmazeutische zusammensetzungen von amlodipin und atorvastatin
DE69831750D1 (de) Biozide und biozide tücher
ATE367376T1 (de) Salz von amlodipin und atorvastatin
EE200100631A (et) Amlodipiini ja atorvastatiini ühised eelravimid
AU2001283085A1 (en) Synergistic effect of amlodipine and atorvastatin
ATE314846T1 (de) Synergistische wirkungen von amlodipin und dem hydroxylierten metabolit von atorvastatin
FR2749049B1 (fr) Embrayage modulaire et sa structure
EP0837689A4 (de) Pharmazeutische zusammensetzungen zur hemmung von metastaten und der angiogenese
FR2760342B1 (fr) Oreiller vegetal anatomo-physiologique
ITBS970011A0 (it) Inferriata componibile modularmente ed amovibile
ZA200108685B (en) Synergistic effects of amlodipine and atorvastatin.
SI1180102T1 (en) Mutual prodrugs of amlodipine and atorvastatin
DE69909610D1 (de) Modulares bördelsystem und bördelkopf
ATE319448T1 (de) Therapeutische zusammensetzung von amlodipin und benazepril
FIU980089U0 (fi) Hyllyn pystyosa sekä hylly
IT234872Y1 (it) Componente di cucine componibili
ATA134997A (de) Sanitäreinrichtung
SE9704040D0 (sv) Dynamisk hantel
SK2184U (sk) Stavebnicová nábytková zostava
DE59800884D1 (de) Tragwerk und dessen konstruktionselemente
SE9802701D0 (sv) Flytt- och möblerbara väggar
DK1064256T3 (da) Bicyclo[2.2.1]heptaner og beslægtede forbindelser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173172

Country of ref document: EP

REN Ceased due to non-payment of the annual fee